ORIGINAL ARTICLE Pain in clinical oncology: Patient satisfaction with management of cancer pain A. Antón 1 , J. Montalar 2 , J. Carulla 3 , C. Jara 4 , N. Batista 5 , C. Camps 6 , J. Cassinello 7 , J. Sanz-Ortiz 8 , E. Díaz-Rubio 9 , C. Martínez 10 , F. Ledesma 10 , E. Zubillaga 10 on behalf of the ALGOS Group † and the DOME III Study Group ‡ 1 Service of Medical Oncology, Hospital Universitario Miguel Servet, Zaragoza, Spain 2 Service of Medical Oncology, Hospital Universitario La Fe, Valencia, Spain 3 Service of Medical Oncology, Hospital Universitari Vall d’Hebron, Barcelona, Spain 4 Service of Medical Oncology, Hospital Hermanos Laguna, Madrid, Spain 5 Service of Medical Oncology, Hospital Universitario de Canarias, La Laguna, Spain 6 Service of Medical Oncology, Hospital General Universitario de Valencia, Valencia, Spain 7 Service of Medical Oncology, Hospital Universitario de Guadalajara, Guadalajara, Spain 8 Service of Medical Oncology, Hospital Universitario Marqués de Valdecilla, Santander, Spain 9 Service of Medical Oncology, Hospital Clínico Universitario San Carlos, Madrid, Spain 10 Medical Department, Janssen-Cilag, Madrid, Spain † ALGOS Group: José Lizón (Hospital Universitario San Juan, Alicante, Spain), Bartomeu Massuti (Hospital General de Alicante, Spain), Enrique Aranda (Hospital Reina Sofía, Córdoba, Spain), Alfredo Carrato (Hospital Ramón y Cajal, Madrid, Spain), Manuel Constenla (Hospital Provincial de Pontevedra, Spain), Juan Jesús Cruz (Hospital Clínico Universitario de Salamanca, Spain), Francisco Javier Dorta (Hospital Nuestra Señora de la Candelaria, Santa Cruz de Tenerife, Spain), Manuel González-Barón (Hospital Universitario La Paz, Madrid, Spain), Vicente Guillem (Instituto Valenciano de Oncología, Valencia, Spain), José Manuel López (Hospital Universitario Marqués de Valdecilla, Santander, Spain), José Andrés Moreno (Hospital General Virgen del Rocío, Sevilla, Spain), Gumersindo Pérez (Hospital General Gregorio Marañón, Madrid, Spain) and Alejandro Tres (Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain). ‡ DOME III Study Group: Ana Blasco (Hospital Universitario de Valencia), Alberto Rodríguez (Hospital Juan Ramón Jiménez, Huelva), Alberto Sáenz (Hospital Clínico de Zaragoza), Alfonso Sánchez (Hospital de Jaén), Alfonso Yubero (Hospital Obispo Polanco, Teruel), Ana Fernández (Hospital Universi- tario Marqués de Valdecilla, Santander), Ángel Rodríguez (Hospital de León), Ángeles López (Hospital Provincial de Castellón), Antonieta Salud (Hospi- tal Arnau de Villanova, Valencia), Beatriz Esteban and Silvia García (Hospital General de Segovia), Bernat Queralt (Hospital Josep Trueta, Girona), Carmen Guillén (Hospital Universitario de Elche, Alicante), Cristina Berecíbar (Unidad Domiciliaria de Cuidados Paliativos, Guipúzcoa), Cristina López (Hospital Policlínico de Vigo), Cristina Nadal and Ma Carme Font (Hospital Clinic, Universitat de Barcelona), Eduardo Polo (Hospital Ernest Lluch de Cal- atayud, Zaragoza), Emilio Esteban (Hospital Universitario Central de Asturias), Enrique Gallardo and Jesús Montesinos (Hospital Parc Taulí, Sabadell, Barcelona), Eva Ma González and José Manuel Rodríguez (Hospital Punta de Europa, Algeciras, Cádiz), Francisco Carabantes (Hospital Carlos Haya, Málaga), Francisco J. Barón (Hospital Universitario de Santiago, A Coruña), Francisco J. Álvarez (Hospital Infanta Cristina, Badajoz), Francisco J. Cevas (Hospital de La Rioja, Logroño), Ignacio Porras (Hospital Reina Sofía, Córdoba), Isabel Fernández (Hospital Universitario de Guadalajara), Javier Puente (Hospital Clínico San Carlos, Madrid), José Antonio Santiago (Hospital Insular de Gran Canaria, La Laguna), José Ramón Mel (Hospital Xeral Calde, Lugo), Juan José Reina (Hospital Juan Ramón Jiménez, Huelva), Juan Luis Martí (Hospital General de Alicante), Juana Ma Cano (Hospital Torrecárdenas, Almería), Ma Ángeles Panadero (Hospital de Coria, Cáceres), Ma Dolores Pineda (Hospital General de Ciudad Real), Ma Esther Uña (Hospital Universi- tario de Valladolid), Ma Luisa González (Hospital Virgen de la Arrixaca, Murcia), Manuel Chaves and Pedro Pastor (Hospital Virgen del Rocío, Sevilla), Mauricio Cuello (Hospital Germans Trias i Pujol, Barcelona), Mercedes Salgado (Complejo Hospitalario de Ourense), Miguel Ángel Lara (Hospital Severo Ochoa, Madrid), Nuria Calvo (Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona), Nuria Láinez (Hospital de Navarra, Pamplona), Paula García (Hospital San Agustín, Avilés, Asturias), Pilar García (Hospital Gregorio Marañón, Madrid), Pilar Vicente (Hospital de Granollers, Barcelona), Pilar Zamora (Hospital Universitario La Paz, Madrid), Salvador Garcerá (Hospital Ribera, Valencia) and Silvia Antolín (Hospital Juan Canalejo, A Coruña). Correspondence Antonio Antón Tel.: +34 976 765648; fax: +34 976 359268. E-mail: aantont@gmail.com Funding sources This study was supported by Janssen-Cilag, S.A. Conflicts of interest None declared Accepted for publication 12 October 2011 doi:10.1002/j.1532-2149.2011.00036.x Abstract Background: Despite effective analgesic therapy, inadequate pain control is frequently perceived by patients and caregivers. Aims: To assess satisfaction with management of pain in cancer patients. Methods: Between January and May 2007, a cross-sectional multicentre study was conducted in 64 Medical Oncology Departments throughout Spain. A total of 525 outpatients with oncological diseases completed a questionnaire with demographic data, characteristics and intensity of pain, and perceptions and attitudes towards pain management at the time of a routine clinical visit. Physicians also completed a questionnaire with tumour-related and treatment-related data. Cluster analysis was used to classify patients into three groups (satisfied, neither satisfied nor 381 Eur J Pain 16 (2012) 381–389 © 2011 European Federation of International Association for the Study of Pain Chapters